Crucial medicines protected for coronavirus patients

The Department of Health and Social Care has announced that more than 80 medicines used to treat patients in intensive care units have been banned from parallel export from the UK.

The ban will help ensure there is an uninterrupted supply of medicines for NHS hospitals treating coronavirus patients. The restrictions cover crucial medicines such as adrenaline, insulin, paracetamol and morphine. All medicines on the list are in high demand across Europe as health systems come under increasing pressure from coronavirus.

Health Minister Lord Bethell said: “Our brilliant NHS staff are going above and beyond to provide world-class care to patients with coronavirus and we are supporting them in every way we can. We are today banning the parallel export of more than 80 crucial medicines to protect patients in the UK and help ensure they can always get the treatments they need.”

Companies that parallel export a medicine on the ban list may face tough enforcement action from the Medicines and Healthcare products Regulatory Agency (MHRA) and risk having their trading licence revoked for serious breaches.

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho